Volume 3, Issue 4 , Pages 207-210, October 2010
Feasibility of simultaneous cognitive behavioral therapy and left prefrontal rTMS for treatment resistant depression
To access this article, please choose from the options below
Partial funding to Dr. Vedeniapin was provided by National Institute on Drug Abuse grant R25 DA020537.
Mark George is an unpaid consultant to several TMS manufacturers (Neuronetics, Brainsway, Neostim, Neosync). Neuronetics loaned the TMS equipment for a recent National Institutes of Health-sponsored TMS trial in depression that Dr. George chaired. The brain stimulation laboratory is conducting a depression clinical trial funded by Brainsway. Dr. George is on the executive committee and is a site Principal Investigator for a Veterans Affairs funded multisite cooperative studies trial of TMS to treat depressed veterans (VA CSP 556).
PII: S1935-861X(10)00047-1
doi:10.1016/j.brs.2010.03.005
© 2010 Elsevier Inc. All rights reserved.
Volume 3, Issue 4 , Pages 207-210, October 2010
